Research Articles

Botlero R, Davis SR, Urquhart DM, Shortread S, Bell RJ. Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire Maturitas. 2009 Feb 20;62(2):134-9.

Lijovic M, Davis SR, Fradkin P, Bradbury J, LaChina M, Schwarz M, Wolfe R, Farrugia H, Bell RJ. The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer Fam Cancer. 2009 Feb 17.

Nijland E A, Nathorst-Boo s J, Palacios S, van de Weijer PW, Davis S, Stathopoulos VM, Birkhaeuser HM, von Mauw E, Mulder RJ and Weijmar Schultz WCM for the LISA study investigators group. Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction. Climacteric 2009;2:114-121.

Chirgwin JH, Lewis J, Woodfield R, Davis SR, Eden J, DeBoer R. Menopause Surveillance Recommendations for Patients with Endocrine Responsive Breast Cancer Cancer Research 2009 69(2):151S.

Davis SR, Wolfe R, Farrugia H, Ferdinand A, Bell RJ. The incidence of invasive breast cancer amongst women using testosterone in the community J Sexual Medicine 2009; 6(7).

Davis SR, Rodenberg C Testosterone for Low Libido Reply.The New England Journal of Medicine 2009;(360)7:728-729.

Wong R, Bell RJ, Thunuguntla K, McNamee K, Vollenhoven B. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users. Contraception 2009 Nov, 80 (5): 452-6.

Panjari M, Bell RJ, Jane F, Wolfe R, Adams J, Morrow C, Davis SR. A randomized trial of oral DHEA treatment for sexual function, well being and menopausal symptoms in postmenopausal women with low libido Journal of Sexual Medicine 2009 Sep 6(9): 257-90.

Bell RJ, Healy DL, Robertson DM, Jobling T, Oehler MK, Edwards A, Shekleton P, Oldham J, Piessens S, Teoh M, Mamers P ,Taylor N and Walker F.  Ovarian status in healthy post-menopausal women: follow-up 12 months after trans-vaginal ultrasound Menopause 2009 Nov-Dec; 16 (6): 1149-55.

Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR. The safety of 52 weeks of oral DHEA therapy in postmenopausal women Maturitas 2009 Jul 20; 63(3) 240-5.

Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR. Lack of knowledge of hormone receptor status is associated with lower prevalence of use of endocrine therapy in women with invasive breast cancer. J Women's Health  2009 Dec; 18 (12): 1975-80.

Davison SL, Bell RJ, La China M, Holden SL, Davis SR. The relationship between self-reported sexual satisfaction and general wellbeing in women. Journal of Sexual Medicine 2009 Oct; 6(10) 2690-7.


Jane F, Davis SR. Chapter 17: Menopause. In:  Women's Health across the Lifespan Ed Laura Hansen, American Society of Health-System Pharmacists Special Publishing, Bethesda MD, USA 2009.